Interesting conference presentation by IMU CEO (Post #:72852559).
Claims that in-vitro trials of onCARlytics and their recently acquired Azer-Cell CD-19 targeting CAR-T therapy killed all cancer cell lines in 72hrs (which apparently is very fast).
ALA-101 has been shown to be effective in-vitro with onCARlytics (also for solid tumors) although no mention about how long it took, so without the actual data it's difficult to compare with Azer-Cell.
The in-vivo trials ALA-101/onCARlytics will be instructive.
onCARlytics update, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $147.2M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.0¢ | 14.0¢ | $9.21K | 65.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 244918 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 135295 | 5 |
View Market Depth
| Last trade - 09.59am 15/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |